Altered amino acid profile in patients with SARS-CoV-2 infection
SARS-COV-2 감염 환자에서 변경된 아미노산 프로파일
Clinical Trial
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Admission
adults hospitalized
Altered
Amino acid
amino acids
arginase
arginine
arginine dysregulation
Arginine-to-ornithine ratio
Asymptomatic
Bioavailability
Biomarker
cellular damage
children
children with COVID-19
citrulline
Cohort
conducted
contribute
Control
controls
coronavirus
COVID-19
determine
dysregulation
Elevation
Endothelial dysfunction
GABR
global arginine bioavailability ratio
healthy
healthy controls
Hospitalized
immune dysregulation
implicated
Infection
Inflammatory
MIS-C
MIS-C. Adult
MIS-C. Adults
multisystem inflammatory syndrome in children
nitric oxide
no difference
observational study
on admission
ornithine
Patient
patients with COVID-19
patients with SARS-CoV-2
Pediatric patient
Pediatric patients
plasma
prospective observational study
respiratory
SARS-CoV-2
Student’s t test
syndrome
T Test
tetrahydrobiopterin
three groups
three patient cohorts
was determined
were assessed
with COVID-19
[DOI] 10.1073/pnas.2101708118 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1073/pnas.2101708118 PMC 바로가기 [Article Type] Clinical Trial